RxDoctor Payments Data

Lori Pai, MD

Hematology & Oncology · Boston, MANPI 1083727911

Payments from drug & device makers

$167,366in general payments, 2019–2025

Across 21 payments — averaging $7969.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Partner Therapeutics, Inc.$125K
  • Novocure Inc.$23K
  • Array Biopharma Inc$19K
  • Johnson & Johnson$78
  • Lilly USA, LLC$30

What the payments were for

  • Education$108100%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$167,366 in reported general payments places this provider in the 65th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$54,394
Medicare patients
108
Services billed
457

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TagrissoOsimertinib Mesylate28$454,016

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →